Medifast, Inc. (MED)

NYSE - Nasdaq Real Time Price. Currency in USD

Visitors trend2W10W9M

119.88

+2.30

(+1.96%)

At close: 04:00PM EST

121.26

+1.38

(+1.15%)

After hours:

04:25PM EST

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Momentum

View all chart patterns

Performance Outlook

Previous Close	117.58
Open	116.82
Bid	109.00 x 1200
Ask	128.00 x 800
Day's Range	116.01 - 121.67
52 Week Range	96.00 - 222.00
Volume	115,279
Avg. Volume	149,484

Market Cap	1.31B
Beta (5Y Monthly)	1.20
PE Ratio (TTM)	9.07
EPS (TTM)	13.21
Earnings Date	Feb 21, 2023 - Feb 27, 2023
Forward Dividend & Yield	6.56 (5.58%)
Ex-Dividend Date	Sep 19, 2022
1y Target Est	106.00

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

103% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MED

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

MEDIFAST INC
MED: What does Argus have to say about MED?MEDIFAST INC has an Investment Rating of HOLD; a target price of $127.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
Rating
Fair Value
Economic Moat
7 days agoArgus Research

All

PR Newswire
Medifast Survey Indicates Consumer Focus on Health and Wellbeing Remains Strong
Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today released findings from a survey designed to further understand the shift in the spending habits of U.S. adults and how they are prioritizing their health and wellbeing heading into 2023.
Motley Fool
Got $1,000? 2 Ultra High-Yield Dividend Stocks to Get Your Hands On
When done right and not for the purpose of simply chasing yield, income investing can drastically alter your perspective of the events going on around you. For investors who have $1,000 to spare after paying bills and building an adequate emergency fund, here are two income stocks with ultra-high dividend yields that appear to be well covered by profits.
- Balchem Corporation Announces Dividend
  GlobeNewswire
- Why Investors Should Love Apple's Dividend
  Motley Fool
Insider Monkey
12 Best High-Yield Dividend Stocks To Buy Now
In this article, we will discuss 12 best high-yield dividend stocks to buy now. You can skip our detailed analysis of high-dividend stocks and their performance over the years, and go directly to read 5 Best High-Yield Dividend Stocks To Buy Now. One of the main aspects of investing in dividend stocks is the sheer focus […]